OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...

Sonora Quest Laboratories has expand its partnership with Centers for Disease Control and Prevention’s (CDC) Increasing Community Access to Testing (ICATT) program to offer free combination COVID-19 a ...

Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill provide key regulatory and reimbursement supportWill assist business developm ...

PrognomiQ - a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early ...

Quest Diagnostics (DGX) announced that Adrienne Brott has been named senior vice president and chief quality and regulatory affairs officer.

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, ...

Mizuho (NYSE:MFG) has updated its US Top Picks list for January, adding Chewy (NYSE:CHWY), GE Vernova (NYSE:GEV), Enliven ...

USA Esoteric Testing Market is expected to show increasing and is expected to grow at a CAGR of ~$% from 2022 to 2028 with the need for early detection & diagnosis & rapid technological advancements ...

Fintel reports that on January 6, 2025, Leerink Partners upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Market ...

Predictive Oncology will enhance our capabilities by assisting oncologists with patient specific diagnostic and therapeutic ...

UC Riverside’s nanopore technology promises faster, more accurate disease diagnostics, revolutionizing healthcare.

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.